GlassScriptPhysician profile
Aakash Garg
NPI 1669872495
$98,637.55
in general payments reported to CMS, 2019-2025
37 companies · $38K in 2025
The $38K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $2,725 · 2021: $8,573 · 2022: $15K · 2023: $13K · 2024: $22K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Travel and Lodging: $23K · Food and Beverage: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,400 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,677.50 |
| Travel and Lodging | $22,515.75 |
| Food and Beverage | $19,781.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,400.00 |
| Education | $191.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $29,468.51 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $27,845.06 | 2021-2025 | Corevalve Evolut R, Resolute Onyx, Onyx Frontier |
| Chiesi USA, INC. | $14,296.40 | 2021-2025 | Kengreal |
| Abbott Laboratories | $9,578.83 | 2019-2025 | Navitor, Mitraclip, Amplatzer Amulet |
| Boston Scientific Corporation | $3,832.77 | 2020-2024 | Watchman Flx, Watchman Access System |
| Cathworks, INC. | $3,050.16 | 2024-2025 | Ffrangio |
| W. L. Gore & Associates, INC. | $2,509.90 | 2021-2023 | Gore Cardioform Septal Occluder |
| Cardiovascular Systems INC. | $921.29 | 2020-2021 | |
| Medical Device Business Services, INC. | $846.48 | 2022 | |
| Abiomed | $831.64 | 2022-2025 | Impella |
| Shockwave Medical, INC | $816.64 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $635.63 | 2021-2024 | (9520) Igt Devices Undivided, (9525) Intracardiac Und |
| Amgen INC. | $525.53 | 2020-2025 | Evenity, Repatha, Prolia |
| E.R. Squibb & Sons, L.L.C. | $408.35 | 2020-2025 | Camzyos, Eliquis |
| Janssen Scientific Affairs, LLC | $388.48 | 2022-2023 | Xarelto |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aakash Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.